A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses

Samuli Ripatti, Emmi Tikkanen, Marju Orho-Melander, Aki S Havulinna, Kaisa Silander, Amitabh Sharma, Candace Guiducci, Markus Perola, Antti Jula, Juha Sinisalo, Marja-Liisa Lokki, Markku S Nieminen, Olle Melander, Veikko Salomaa, Leena Peltonen, Sekar Kathiresan, Samuli Ripatti, Emmi Tikkanen, Marju Orho-Melander, Aki S Havulinna, Kaisa Silander, Amitabh Sharma, Candace Guiducci, Markus Perola, Antti Jula, Juha Sinisalo, Marja-Liisa Lokki, Markku S Nieminen, Olle Melander, Veikko Salomaa, Leena Peltonen, Sekar Kathiresan

Abstract

Background: Comparison of patients with coronary heart disease and controls in genome-wide association studies has revealed several single nucleotide polymorphisms (SNPs) associated with coronary heart disease. We aimed to establish the external validity of these findings and to obtain more precise risk estimates using a prospective cohort design.

Methods: We tested 13 recently discovered SNPs for association with coronary heart disease in a case-control design including participants differing from those in the discovery samples (3829 participants with prevalent coronary heart disease and 48,897 controls free of the disease) and a prospective cohort design including 30,725 participants free of cardiovascular disease from Finland and Sweden. We modelled the 13 SNPs as a multilocus genetic risk score and used Cox proportional hazards models to estimate the association of genetic risk score with incident coronary heart disease. For case-control analyses we analysed associations between individual SNPs and quintiles of genetic risk score using logistic regression.

Findings: In prospective cohort analyses, 1264 participants had a first coronary heart disease event during a median 10·7 years' follow-up (IQR 6·7-13·6). Genetic risk score was associated with a first coronary heart disease event. When compared with the bottom quintile of genetic risk score, participants in the top quintile were at 1·66-times increased risk of coronary heart disease in a model adjusting for traditional risk factors (95% CI 1·35-2·04, p value for linear trend=7·3×10(-10)). Adjustment for family history did not change these estimates. Genetic risk score did not improve C index over traditional risk factors and family history (p=0·19), nor did it have a significant effect on net reclassification improvement (2·2%, p=0·18); however, it did have a small effect on integrated discrimination index (0·004, p=0·0006). Results of the case-control analyses were similar to those of the prospective cohort analyses.

Interpretation: Using a genetic risk score based on 13 SNPs associated with coronary heart disease, we can identify the 20% of individuals of European ancestry who are at roughly 70% increased risk of a first coronary heart disease event. The potential clinical use of this panel of SNPs remains to be defined.

Funding: The Wellcome Trust; Academy of Finland Center of Excellence for Complex Disease Genetics; US National Institutes of Health; the Donovan Family Foundation.

Copyright © 2010 Elsevier Ltd. All rights reserved.

Figures

Figure
Figure
Distributions at baseline of genetic risk score, LDL cholesterol, systolic blood pressure, and log-transformed C-reactive protein by 10-year incident coronary heart disease event status in FINRISK 1992 and 1997 cohorts Data for C-reactive protein only available in FINRISK 1997. CHD=coronary heart disease.

References

    1. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J., 3rd Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50.
    1. Musunuru K, Kathiresan S. Genetics of coronary artery disease. Annu Rev Genomics Hum Genet. 2010;11:91–108.
    1. Healy DG. Case-control studies in the genomic era: a clinician's guide. Lancet Neurol. 2006;5:701–707.
    1. Vartiainen E, Laatikainen T, Peltonen M. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol. 2009;12:1–15.
    1. Kattainen A, Salomaa V, Härkänen T. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J. 2006;27:296–301.
    1. Heistaro S, editor. Methodology report. Health 2000 survey. National Public Health Institute; Helsinki, Finland: 2008. (accessed Feb 16, 2010).
    1. Berglund G, Elmstähl S, Janzon L, Larsson SA. The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med. 1993;233:45–51.
    1. Persson M, Hedblad B, Nelson JJ, Berglund G. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol. 2007;27:1411–1416.
    1. Pajunen P, Koukkunen H, Ketonen M. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12:132–137.
    1. Tolonen H, Salomaa V, Torppa J, Sivenius J, Immonen-Räihä P, Lehtonen A. The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses. Eur J Cardiovasc Prev Rehabil. 2007;14:380–385.
    1. Kathiresan S, Melander O, Anevski D. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358:1240–1249.
    1. Langholz B, Goldstein L. Risk set sampling in epidemiologic cohort studies. Stat Sci. 1996;11:35–53.
    1. Helgadottir A, Thorleifsson G, Manolescu A. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491–1493.
    1. Samani N, Erdmann J, Hall S. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:1–11.
    1. Myocardial Infarction Genetics Consortium Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;41:334–341.
    1. Erdmann J, Grobhennig A, Braund P. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009;41:280–282.
    1. Gudbjartsson D, Bjornsdottir U, Halapi E. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41:342–347.
    1. Clarke R, Peden J, Hopewell J. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361:2518–2528.
    1. McPherson R, Pertsemlidis A, Kavaslar N. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491.
    1. Schoenfeld D. Residuals for the proportional hazards regression model. Biometrika. 1982;69:239–241.
    1. Hedges L, Olkin I. Statistical methods for meta-analysis. Academic Press; London: 1985.
    1. Heagerty PJ, Lumley T, Pepe MS. Time dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337–344.
    1. Antolini L, Nam BH, D'Agostico RB. Inference on correlated discrimination measures in survival analysis: A nonparametric approach. Commun Stat Theory Methods. 2004;33:2117–2135.
    1. Cook NR. Comments on “Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond” by M. J. Pencina et al., Statistics in Medicine (DOI:10.1002/sim.2929) Stat Med. 2008;27:191–195.
    1. Steyerberg EW, Pencina MJ. Reclassification calculations for persons with incomplete follow-up. Ann Intern Med. 2010;152:195–196.
    1. Pencina M, D'Agostino RS, D'Agostino RJ, Vasan R. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.
    1. Melander O, Newton-Cheh C, Almgren P. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009;302:49–57.
    1. Ware J. The limitations of risk factors as prognostic tools. N Engl J Med. 2006;355:2615–2617.
    1. Paynter NP, Chasman DI, Paré G. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA. 2010;303:631–637.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa